Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model
The EphA2 tyrosine kinase receptor is highly expressed in several types of solid tumors. In our recent studies, we targeted EphA2 in pancreatic cancer with agonistic agents and demonstrated that suppression of EphA2 significantly reduced cancer-cell migration in cell-based assays. In the present stu...
Main Authors: | Ahmed F. Salem, Luca Gambini, Sandrine Billet, Yu Sun, Hiromichi Oshiro, Ming Zhao, Robert M. Hoffman, Neil A. Bhowmick, Maurizio Pellecchia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/2854 |
Similar Items
-
EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice
by: K’Shylah S. Whitehurst, et al.
Published: (2020-08-01) -
Der Einfluss der Hypoxie auf die Expression und Synthese verschiedener Eph-Rezeptoren und Ephrin-Liganden beim malignen Melanom
by: Reißenweber, Bettina
Published: (2013) -
Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents
by: Ahmed F. Salem, et al.
Published: (2020-05-01) -
Targeting EphA2 in cancer
by: Ta Xiao, et al.
Published: (2020-08-01) -
Anti-EphA2 Antibodies Decrease EphA2 Protein Levels in Murine CT26 Colorectal and Human MDA-231 Breast Tumors But Do Not Inhibit Tumor Growth
by: David Kiewlich, et al.
Published: (2006-01-01)